3-Year Clinical Outcome of the DUTCH PEERS (TWENTE II) Randomized Trial: Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Versus Platinum-Chromium Everolimus-Eluting Promus Element Stents in All-Comer Patients

被引：0

作者：

von Birgelen, Clemens ^{[1
,2
]}

van der Heijden, Liefke C. ^{[1
]}

Kok, Marlies M. ^{[1
]}

Danse, Peter W. ^{[3
]}

Jessurun, Gillian A. ^{[4
]}

Hautvast, Raymond ^{[5
]}

Hartmann, Marc ^{[1
]}

Gin, Melvyn Tjon Joe ^{[3
]}

Schramm, Alexander ^{[4
]}

Louwerenburg, Hans W. ^{[1
]}

Lowik, Marije M. ^{[1
]}

Linssen, Gerard C. ^{[6
]}

Doggen, Carine J. ^{[7
]}

Stoel, Martin G. ^{[1
]}

机构：

[1] Thoraxctr Twente, Enschede, Netherlands

[2] Univ Twente, NL-7500 AE Enschede, Netherlands

[3] Rijnstate Hosp, Arnhem, Netherlands

[4] Scheper Hosp, Emmen, Netherlands

[5] Med Ctr Alkmaar, Alkmaar, Netherlands

[6] Ziekenhuisgrp Twente, Almelo, Netherlands

[7] MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 15期

关键词：

Everolimus-eluting stents; Randomized clinical trial; Zotarolimus-eluting stent;

D O I：

10.1016/j.jacc.2015.08.1040

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-570

引用

页码：B231 / B231

页数：1

共 41 条

[21] Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting Xience V stents: two-year clinical outcome in the gender-stratified randomized, controlled TWENTE trial
Tandjung, K.
Sen, H.
Lam, M. K.
Stoel, M. G.
De Man, F. H. A. F.
Louwerenburg, J. W.
Linssen, G. C. M.
Nijhuis, R.
Nienhuis, M. B.
Von Birgelen, C.
EUROPEAN HEART JOURNAL, 2013, 34 : 221 - 222
[22] Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial
von Birgelen, Clemens
Sen, Hanim
Lam, Ming Kai
Danse, Peter W.
Jessurun, Gillian A. J.
Hautvast, Raymond W. M.
van Houwelingen, Gert K.
Schramm, Alexander R.
Gin, R. Melvyn Tjon Joe
Louwerenburg, Johannes W.
de Man, Frits H. A. F.
Stoel, Martin G.
Lowik, Marije M.
Linssen, Gerard C. M.
Said, Salah A. M.
Nienhuis, Mark B.
Verhorst, Patrick M. J.
Basalus, Mounir W. Z.
Doggen, Carine J. M.
Tandjung, Kenneth
LANCET, 2014, 383 (9915): : 413 - 423
[23] Clinical Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From DUTCH PEERS (TWENTE II) Randomized Trial
van Houwelingen, K. Gert
van der Heijden, Liefke
Lam, Ming Kai
Lowik, Marije
Danse, Peter
Gin, R. Melvyn Tjon Joe
Jessurun, Gillian A.
Anthonio, Rutger L.
Sen, Hanim
Linssen, Gerard C. M.
IJzerman, Maarten J.
Doggen, Carine J. M.
von Birgelen, Clemens
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B70 - B70
[24] Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent-3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial -
Kim, Chee Hae
Park, Kyung Woo
Kang, Jeehoon
Park, Byoung-Eun
Cha, Kwang Soo
Rhew, Jay Young
Jeon, Hui-Kyung
Shin, Eun-Seok
Oh, Ju Hyeon
Jeong, Myung-Ho
Kim, Sanghyun
Hwang, Kyung-Kuk
Yoon, Jung-Han
Lee, Sung Yun
Park, Tae-Ho
Moon, Keon Woong
Kwon, Hyuck-Moon
Hur, Seung-Ho
Ryu, Jae-Kean
Lee, Bong-Ryul
Park, Yong Whi
Chae, In-Ho
Kim, Hyo-Soo
CIRCULATION JOURNAL, 2019, 83 (07) : 1489 - +
[25] Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients
Miyazaki, Tadashi
Latib, Azeem
Panoulas, Vasileios F.
Miyazaki, Sakiko
Costopoulos, Charis
Sato, Katsumasa
Naganuma, Toru
Kawamoto, Hiroyoshi
Daida, Hiroyuki
Colombo, Antonio
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (01) : E11 - E18
[26] Twelve-Months Clinical Efficacy and Safety of Zotarolimus (Endeavor ResoluteTM)- versus Platinum Chromium based Everolimus-Eluting Stents (Promus ElementTM) in Asian Patients
Kim, SunWon
Rha, Seung-Woon
Elnagar, Amro
Choi, Byoung Geol
Im, Sung Il
Na, Jin Oh
Han, Seong Woo
Choi, Cheol Ung
Lim, Hong Euy
Kim, Jin Won
Kim, Eung Ju
Seo, Hong Seog
Park, Chang Gyu
Oh, Dong Joo
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 32S - 32S
[27] Three-Year Clinical Outcome of Patients Treated With the Nobori Biolimus-Eluting Stent and Xience/Promus Cobalt-Chromium Everolimus-Eluting Stent for Unprotected Left Main Disease
Hiromasa, Takashi
Kuramitsu, Shoichi
Jinnouchi, Hiroyuki
Morinaga, Takashi
Kobayashi, Yohei
Domei, Takenori
Hyodo, Makoto
Soga, Yoshimitsu
Shirai, Shinichi
Ando, Kenji
CIRCULATION, 2016, 134
[28] Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study
Moreno, Raul
Legrand, Victor
Ferrario, Maurizio
MacCarthy, Philip
Redwood, Simon
Werner, Nikos
Jung, Werner
Ungi, Imre
Zaman, Azfar
Richardt, Gert
Crowley, James
Schwimmbeck, Peter
Christen, Thomas
Allocco, Dominic J.
Meredith, Ian T.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (03) : 398 - 403
[29] Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial (vol 383, pg 413, 2014)
von Birgelen, C.
Sen, H.
Lam, M. K.
LANCET, 2014, 383 (9915): : 412 - 412
[30] Three-year clinical outcome of patients treated with the Nobori biolimus-eluting stent and Xience/Promus cobalt-chromium everolimus-eluting stent for unprotected left main disease
Hiromasa, Takashi
Kuramitsu, Shoichi
Jinnouchi, Hiroyuki
Domei, Takenori
Yamaji, Kyohei
Hyodo, Makoto
Soga, Yoshimitsu
Shirai, Shinichi
Ando, Kenji
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B120 - B120

← 1 2 3 4 5 →